Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
652K
-
Shares change
-
+37.5K
-
Total reported value, excl. options
-
$143M
-
Value change
-
+$8.24M
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$219.89
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2023
7 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q4 2023.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 652K shares
of 44.8M outstanding shares and own 1.46% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.3M shares), VANGUARD GROUP INC (4.67M shares), WELLINGTON MANAGEMENT GROUP LLP (3.79M shares), Avoro Capital Advisors LLC (2.86M shares), FMR LLC (2.32M shares), RENAISSANCE TECHNOLOGIES LLC (2.17M shares), STATE STREET CORP (1.95M shares), JANUS HENDERSON GROUP PLC (870K shares), GEODE CAPITAL MANAGEMENT, LLC (780K shares), and DIMENSIONAL FUND ADVISORS LP (562K shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.